1、F-1 1 ea0204138-05.htm REGISTRATION STATEMENTAs filed with the U.S.Securities and Exchange Commission on August 26,2024.Registration No.333-UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549_FORM F-1REGISTRATION STATEMENTUNDERTHE SECURITIES ACT OF 1933_Park Ha Biological Technology

2、Co.,Ltd.(Exact name of registrant as specified in its charter)_Not Applicable(Translation of Registrants Name into English)_Cayman Islands 5990 Not Applicable(State or otherjurisdiction ofincorporation ororganization)(Primary StandardIndustrialClassification Code Number)(I.R.S.EmployerIdentification

3、 Number)901&901-2,Building CPhase 2,Wuxi International Life Science Innovation Campus196 Jinghui East RoadXinwu District,Wuxi,Jiangsu ProvincePeoples Republic of China 214000+86 400 012 7562(Address,including zip code,and telephone number,including area code,of principalexecutive offices)_Cogency Gl

4、obal Inc.122 East 42nd Street,18th FloorNew York,NY 10168+1(212)947-7200(Name,address,including zip code,and telephone number,including area code,ofagent for service)_Copies to:William S.Rosenstadt,Esq.Mengyi“Jason”Ye,Esq.Grace Bai,Esq.Ortoli Rosenstadt LLP366 Madison Avenue,3rdFloorNewYork,NY10017T

5、elephone:+1(212)588-0022 Ying Li,Esq.Guillaume de Sampigny,Esq.Hunter Taubman Fischer&Li LLC950 Third Avenue,19th FloorNew York,NY 10022Telephone:+1 212-530-2206_Approximate date of commencement of proposed sale to public:As soon as practicable after theeffective date of this Registration Statement.

6、If any securities being registered on this Form are to be offered on a delayed or continuousbasis pursuant to Rule415 under the Securities Act,check the following box.If this Form is filed to register additional securities for an offering pursuant toRule 462(b)under the Securities Act,check the foll